JP2011524362A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011524362A5 JP2011524362A5 JP2011513674A JP2011513674A JP2011524362A5 JP 2011524362 A5 JP2011524362 A5 JP 2011524362A5 JP 2011513674 A JP2011513674 A JP 2011513674A JP 2011513674 A JP2011513674 A JP 2011513674A JP 2011524362 A5 JP2011524362 A5 JP 2011524362A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- formula
- halo
- neurofibromatosis
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6115608P | 2008-06-13 | 2008-06-13 | |
| US61/061,156 | 2008-06-13 | ||
| PCT/US2009/046971 WO2009152288A1 (en) | 2008-06-13 | 2009-06-11 | Substituted benzimidazoles for neurofibromatosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011524362A JP2011524362A (ja) | 2011-09-01 |
| JP2011524362A5 true JP2011524362A5 (https=) | 2012-07-26 |
Family
ID=40956523
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011513674A Withdrawn JP2011524362A (ja) | 2008-06-13 | 2009-06-11 | 神経線維腫症用の置換ベンゾイミダゾール |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20110092546A1 (https=) |
| EP (1) | EP2288354A1 (https=) |
| JP (1) | JP2011524362A (https=) |
| KR (1) | KR20110025827A (https=) |
| CN (1) | CN102065859B (https=) |
| AU (1) | AU2009257487B2 (https=) |
| BR (1) | BRPI0915106A2 (https=) |
| CA (1) | CA2726376A1 (https=) |
| MX (1) | MX2010013683A (https=) |
| RU (1) | RU2011100106A (https=) |
| TW (1) | TW201004621A (https=) |
| WO (1) | WO2009152288A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9540443B2 (en) | 2011-01-26 | 2017-01-10 | Kolltan Pharmaceuticals, Inc. | Anti-kit antibodies |
| NZ630363A (en) | 2012-07-25 | 2018-09-28 | Celldex Therapeutics Inc | Anti-kit antibodies and uses thereof |
| CN113975386A (zh) | 2014-05-23 | 2022-01-28 | 塞尔德克斯医疗公司 | 嗜酸性粒细胞或肥大细胞相关病症的治疗 |
| KR101880015B1 (ko) | 2017-12-08 | 2018-07-19 | 아주대학교산학협력단 | 인터페론 감마를 유효성분으로 함유하는 신경섬유육종 예방 또는 치료용 조성물 |
| CN113784713A (zh) | 2019-01-11 | 2021-12-10 | 纳吉斯制药股份有限公司 | 白三烯合成抑制剂 |
| WO2022268158A1 (zh) * | 2021-06-23 | 2022-12-29 | 正大天晴药业集团股份有限公司 | 作为c-Met激酶抑制剂的化合物治疗I型神经纤维瘤病的用途 |
| EP4412610A1 (en) * | 2021-10-08 | 2024-08-14 | Université Claude Bernard Lyon 1 | Benzimidazole derivatives for use in the treatment or prevention of a histiocytosis or a craniopharyngioma |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003082272A1 (en) * | 2002-03-29 | 2003-10-09 | Chiron Corporation | Substituted benzazoles and use thereof as raf kinase inhibitors |
| TWI387592B (zh) * | 2005-08-30 | 2013-03-01 | Novartis Ag | 經取代之苯并咪唑及其作為與腫瘤形成相關激酶之抑制劑之方法 |
| GB0609378D0 (en) * | 2006-05-11 | 2006-06-21 | Novartis Ag | Organic compounds |
| PE20130814A1 (es) * | 2006-08-30 | 2013-08-08 | Novartis Ag | Sales de benzimidazolil piridil eteres y formulaciones que las contienen |
| WO2008070616A2 (en) * | 2006-12-01 | 2008-06-12 | University Of Utah Research Foundation | METHODS AND COMPOSITIONS RELATED TO HIF-1α |
| CA2924436A1 (en) * | 2007-07-30 | 2009-02-05 | Ardea Biosciences, Inc. | Pharmaceutical combinations of n-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide as inhibitors of mek and methods of use |
| WO2009114703A2 (en) * | 2008-03-12 | 2009-09-17 | Fox Chase Cancer Center | Combination therapy for the treatment of cancer |
-
2009
- 2009-06-11 KR KR1020117000776A patent/KR20110025827A/ko not_active Withdrawn
- 2009-06-11 MX MX2010013683A patent/MX2010013683A/es not_active Application Discontinuation
- 2009-06-11 CN CN2009801221827A patent/CN102065859B/zh not_active Expired - Fee Related
- 2009-06-11 EP EP09763578A patent/EP2288354A1/en not_active Ceased
- 2009-06-11 CA CA2726376A patent/CA2726376A1/en not_active Abandoned
- 2009-06-11 US US12/997,770 patent/US20110092546A1/en not_active Abandoned
- 2009-06-11 BR BRPI0915106A patent/BRPI0915106A2/pt not_active IP Right Cessation
- 2009-06-11 AU AU2009257487A patent/AU2009257487B2/en not_active Ceased
- 2009-06-11 JP JP2011513674A patent/JP2011524362A/ja not_active Withdrawn
- 2009-06-11 WO PCT/US2009/046971 patent/WO2009152288A1/en not_active Ceased
- 2009-06-11 RU RU2011100106/15A patent/RU2011100106A/ru not_active Application Discontinuation
- 2009-06-12 TW TW098119822A patent/TW201004621A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011524362A5 (https=) | ||
| JP2011502958A5 (https=) | ||
| JP2014511869A5 (https=) | ||
| JP2009534386A5 (https=) | ||
| JP2018515555A5 (https=) | ||
| JP2015500326A5 (https=) | ||
| JPWO2012144463A1 (ja) | 腫瘍治療剤 | |
| JP2004512328A5 (https=) | ||
| JP2014507464A5 (https=) | ||
| JP2017505293A5 (https=) | ||
| JP2014502979A5 (https=) | ||
| JP2010516701A5 (https=) | ||
| IL273000B2 (en) | Compounds that inhibit lysophosphatidic acid receptor 1 (lpar1) | |
| JP2009501745A5 (https=) | ||
| JP2006501201A5 (https=) | ||
| JP2016540811A5 (https=) | ||
| JP2017509694A5 (https=) | ||
| JP2017536342A5 (https=) | ||
| RU2011100106A (ru) | Замещенные бензимидазолы для лечения нейрофиброматоза | |
| JP2009541387A5 (https=) | ||
| JP2005505583A5 (https=) | ||
| JP2020515645A5 (https=) | ||
| RU2015150614A (ru) | Новые 3, 4-дигидро-2н-изохинолин-1-оны и 2, 3-дигидро-изоиндол-1-оны | |
| JP2019529487A5 (https=) | ||
| JP2018522915A5 (https=) |